Regional differences in cingulate metabolite ratios were substantially larger and more robust than longitudinal changes observed across an approximately 34-hour protocol, according to a prospective proton magnetic resonance spectroscopy study. Researchers evaluated whether baseline differences between the anterior cingulate cortex and posterior cingulate cortex exceeded changes measured over time, assessing whether these observations depended on acquisition sequences, spectral quality-control standards, respiratory burden, clinical comorbidities, or objective polysomnographic sleep metrics.
The prospective single-center investigation enrolled 138 participants who completed baseline evening spectroscopy of the anterior and posterior cingulate cortices on day 1. Participants subsequently underwent full-night polysomnography running from day 2 into day 3, followed by post-polysomnography morning spectroscopy on day 3. Measurements were acquired using two distinct acquisition approaches, MEGA-PRESS and SVS-PRESS. Among the 116 participants with complete paired timestamps, the median interval between scan starts was 34.01 hours, with an interquartile range of 33.86 to 34.10 hours.
To evaluate metabolite-to-creatine ratios, the investigators utilized generalized estimating equations adjusted for participant age, sex, and body mass index, with 137 participants contributing data to the adjusted primary statistical models. In these analyses, Cr2 represented the vendor-fitted second creatine and phosphocreatine resonance, whereas GlxT denoted the composite sum of six vendor-fitted glutamate and glutamine components.
The primary models revealed clear anatomical divergence between the two examined cingulate regions. The posterior cingulate cortex exhibited higher NAA/Cr across both acquisition sequences, higher SVS GlxT/Cr, and higher MEGA GABA/Cr (q = 0.020). Conversely, the anterior cingulate cortex demonstrated higher Cho/Cr across both sequences and higher MEGA Glu/Cr, with all of these primary contrasts reaching significance at q < 0.001. In contrast, longitudinal reductions that survived false discovery rate correction were strictly confined to SVS Cr2/Cr and SVS GlxT/Cr.
Quantifying the disparity between anatomical location and time-dependent change, the median absolute paired standardized effect size across 11 outcomes was 0.571 for regional differences compared to 0.125 for longitudinal change. The regional effect magnitude was 4.6 times that of the longitudinal change, representing a comparison of standardized effect magnitudes rather than a biological fold difference between metabolic concentrations.
Sensitivity analyses evaluated effect magnitude, sequence dependence, spectral-quality selection, follow-up availability, the exclusion of participants with hypertension or diabetes, and associations with seven polysomnographic measures. Excluding participants with an apnea-hypopnea index of 15 or more events per hour preserved the direction of all 12 primary false discovery rate-significant effects, with 11 retaining significance at q < 0.05. Furthermore, none of the 77 polysomnographic dose-response tests survived global correction.
The authors stressed critical interpretive boundaries regarding the protocol. Because the approximately 34-hour interval combined elapsed time, circadian phase differences, an intervening monitored night, participant repositioning, and other uncontrolled influences, the longitudinal alterations should not be interpreted as sleep-specific effects. Additionally, because the measurements relied on metabolite-to-creatine ratios, the reported findings cannot be interpreted as regional tissue concentration differences.
The prospective investigation was conducted by researchers from the Department of Radiology and the Department of Neurology at The First Affiliated Hospital of Chongqing Medical University in Chongqing, China, including Sihang Wang, Youquan Ning, Zhiwei Zhang, Bin Yu, Hao Wu, Yilan Li, Lian He, Yida Hu, and Fajin Lv. The work was published in Frontiers in Medicine within the Medical Imaging and Nuclear Medicine section.
Subject of Research: Cingulate cortex metabolite ratio differences and longitudinal changes in proton magnetic resonance spectroscopy
Article Title: Regional cingulate metabolite-ratio differences exceed longitudinal changes across an approximately 34-h protocol: a prospective quality-controlled proton magnetic resonance spectroscopy study
Article References: Wang, S., Ning, Y., Zhang, Z., Yu, B., Wu, H., Li, Y., He, L., Hu, Y., & Lv, F. (2026). Regional cingulate metabolite-ratio differences exceed longitudinal changes across an approximately 34-h protocol: a prospective quality-controlled proton magnetic resonance spectroscopy study. Frontiers in Medicine, 13, Article 1990412. https://doi.org/10.3389/fmed.2026.1990412
Image Credits: AI Generated
DOI: 10.3389/fmed.2026.1990412
Keywords: Proton magnetic resonance spectroscopy, Anterior cingulate cortex, Posterior cingulate cortex, MEGA-PRESS, SVS-PRESS, Polysomnography, Metabolite ratios, Longitudinal change, Creatine ratio, N-acetylaspartate, Choline, Glutamate, GABA, Quality control, Generalized estimating equations, Apnea-hypopnea index
Cite Scienmag News
Ophelia Keating. (November 16, 2026). Regional Cingulate Metabolite Ratio Differences Exceed Longitudinal Changes Across 34 Hours. Scienmag. https://scienmag.com/regional-cingulate-metabolite-ratio-differences-exceed-longitudinal-changes-across-34-hours/
Ophelia Keating. "Regional Cingulate Metabolite Ratio Differences Exceed Longitudinal Changes Across 34 Hours." Scienmag, 16 November 2026, https://scienmag.com/regional-cingulate-metabolite-ratio-differences-exceed-longitudinal-changes-across-34-hours/. Accessed 16 November 2026.
Ophelia Keating. "Regional Cingulate Metabolite Ratio Differences Exceed Longitudinal Changes Across 34 Hours." Scienmag. November 16, 2026. https://scienmag.com/regional-cingulate-metabolite-ratio-differences-exceed-longitudinal-changes-across-34-hours/








